LAHORE: Only three percent of cancer patients in Pakistan are diagnosed at an early and curable stage, while 22 percent are ...

Nearly 75 per cent of cancer patients in Pakistan are diagnosed when the disease has advanced to stage three or four, leaving limited treatment options and poor chances of survival, leading ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The DESTINY-Endometrial01 study aims to evaluate the ...

Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration with Merck Sharp & Dohme LLC, is ...